These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7700837)

  • 1. GRF-induced feeding: evidence for protein selectivity and opiate involvement.
    Dickson PR; Vaccarino FJ
    Peptides; 1994; 15(8):1343-52. PubMed ID: 7700837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of feeding behavior induced by central injection of GRF.
    Dickson PR; Vaccarino FJ
    Am J Physiol; 1990 Sep; 259(3 Pt 2):R651-7. PubMed ID: 2118735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intra-arcuate opiate actions stimulate GRF-dependent and protein-selective feeding.
    Vaccarino FJ; Taube MR
    Peptides; 1997; 18(2):197-205. PubMed ID: 9149291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of hypothalamic administration of growth hormone-releasing factor (GRF) on feeding behavior in rats.
    Tanaka Y; Egawa M; Inoue S; Takamura Y
    Brain Res; 1991 Sep; 558(2):273-9. PubMed ID: 1782544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microinjections of growth hormone-releasing factor into the medial preoptic area/suprachiasmatic nucleus region of the hypothalamus stimulate food intake in rats.
    Vaccarino FJ; Hayward M
    Regul Pept; 1988 May; 21(1-2):21-8. PubMed ID: 3134673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphine-stimulated feeding: analysis of macronutrient selection and paraventricular nucleus lesions.
    Shor-Posner G; Azar AP; Filart R; Tempel D; Leibowitz SF
    Pharmacol Biochem Behav; 1986 Apr; 24(4):931-9. PubMed ID: 3086905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of endogenous GRF at dark onset selectively suppresses protein intake.
    Dickson PR; Feifel D; Vaccarino FJ
    Peptides; 1995; 16(1):7-9. PubMed ID: 7716077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone-releasing factor affects macronutrient intake during the anabolic phase of zinc repletion: total hypothalamic growth hormone-releasing factor content and growth hormone-releasing factor immunoneutralization during zinc repletion.
    Rains TM; Mangian HF; Liang T; Cole AC; Beverly JL; Shay NF
    Nutr Neurosci; 2001; 4(4):283-93. PubMed ID: 11842895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meal patterns and macronutrient intake after peripheral and PVN injections of the alpha 2-receptor antagonist idazoxan.
    Alexander JT; Cheung WK; Dietz CB; Leibowitz SF
    Physiol Behav; 1993 Apr; 53(4):623-30. PubMed ID: 8099748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the opioid antagonist naltrexone on feeding induced by DAMGO in the central nucleus of the amygdala and in the paraventricular nucleus in the rat.
    Giraudo SQ; Billington CJ; Levine AS
    Brain Res; 1998 Jan; 782(1-2):18-23. PubMed ID: 9519245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of dietary preference and galanin administration in the paraventricular or amygdaloid nucleus on diet self-selection.
    Smith BK; York DA; Bray GA
    Brain Res Bull; 1996; 39(3):149-54. PubMed ID: 8866690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paraventricular opioids alter intake of high-fat but not high-sucrose diet depending on diet preference in a binge model of feeding.
    Naleid AM; Grace MK; Chimukangara M; Billington CJ; Levine AS
    Am J Physiol Regul Integr Comp Physiol; 2007 Jul; 293(1):R99-105. PubMed ID: 17428895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antagonism of central growth hormone-releasing factor activity selectively attenuates dark-onset feeding in rats.
    Vaccarino FJ; Feifel D; Rivier J; Vale W
    J Neurosci; 1991 Dec; 11(12):3924-7. PubMed ID: 1744698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for a mu-opioid-opioid connection between the paraventricular nucleus and ventral tegmental area in the rat.
    Quinn JG; O'Hare E; Levine AS; Kim EM
    Brain Res; 2003 Nov; 991(1-2):206-11. PubMed ID: 14575893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Administration of kisspeptin-54 into discrete regions of the hypothalamus potently increases plasma luteinising hormone and testosterone in male adult rats.
    Patterson M; Murphy KG; Thompson EL; Patel S; Ghatei MA; Bloom SR
    J Neuroendocrinol; 2006 May; 18(5):349-54. PubMed ID: 16629833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naloxone blockade of growth hormone-releasing factor-induced feeding.
    Vaccarino FJ; Buckenham KE
    Regul Pept; 1987 Aug; 18(3-4):165-71. PubMed ID: 3118423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of PVN galanin on macronutrient selection.
    Tempel DL; Leibowitz KJ; Leibowitz SF
    Peptides; 1988; 9(2):309-14. PubMed ID: 2453854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microinjection of galanin-like peptide into the medial preoptic area stimulates food intake in adult male rats.
    Patterson M; Murphy KG; Thompson EL; Smith KL; Meeran K; Ghatei MA; Bloom SR
    J Neuroendocrinol; 2006 Oct; 18(10):742-7. PubMed ID: 16965292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paraventricular nucleus injections of peptide YY and neuropeptide Y preferentially enhance carbohydrate ingestion.
    Stanley BG; Daniel DR; Chin AS; Leibowitz SF
    Peptides; 1985; 6(6):1205-11. PubMed ID: 3841735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRF alters the infundibular LHRH secretory system from the medial preoptic area of female rats: possible involvement of opioid receptors.
    Rivest S; Plotsky PM; Rivier C
    Neuroendocrinology; 1993; 57(2):236-46. PubMed ID: 8389996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.